11A-1100728
TW I814499、US pending
Synthesis of ribonucleic acid (RNA) is an important step in the development of various RNA drugs and vaccines. Current technology uses solid-phase synthesis or enzymatic transcription methods to prepare RNA. Solid-phase synthesis can only prepare RNA of 60-80 nucleotides, and the yield of RNA decreases significantly as the nucleotide length increases. The enzymatic transcription method is used to prepare RNA in batches. Due to the delay time between batches or reactions and the risk of contamination during sample transportation, the efficiency of preparing RNA in batches is not high. This technology develops a device for continuously synthesizing and analyzing RNA, including an in vitro transcription module, a decomposition module, and a processor coupled to the transcription module and the decomposition module. The device provides the ability to automatically produce RNA continuously over a long period of time, reducing labor requirements, process errors and batch-to-batch variability. The continuous conjoined process can effectively control the process temperature, accelerate the rate of sample heating and cooling, help reduce reaction steps to reduce the risk of contamination and increase yield, and is easy to perform from small-volume testing to large-scale production.
- Continuous operation to avoid deadtime between batches.
- Controlled shear stress and stable laminar flow for effective mixing in gentle conditions to minimize protein-nucleic dissociation.
- Precise control of reaction time, and real-time in situ control of RNA growth.
- Reaction condition in small scale can be directly applied for large scale reaction.
Research, development, and production of RNA drugs and vaccines.
James C. Liao and Yi-Chung Tung
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Devices for Synthesizing Ribonucleic Acids